Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Cefazolin plus aminoglycoside compared to piperacillin-tazobactam for type 3 open fractures
FY 2022-23
Summary
Open fractures represent a significant cause of morbidity worldwide, leading to disability and even the potential for limb loss. Moreover, the impact of these injuries disproportionately affects those in the developing world. While surgical treatment of these injuries is focused on thorough irrigation and debridement along with fracture stabilization, early antibiotic prophylaxis is consistently identified as one of the greatest contributors to decreasing the risk of surgical site infection (SSI). Guidelines currently recommend the use of a cephalosporin such as cefazolin for antibiotic prophylaxis, with the addition of an aminoglycoside for those more severe Type III open fractures in order to provide Gram-negative coverage. More recently, literature has demonstrated promise with regards to the use of piperacillin-tazobactam as an alternative to cefazolin plus an aminoglycoside, potentially avoiding the known complications of nephrotoxicity and ototoxicity associated with aminoglycosides.
The PREP-IT trials are a group of large, multicenter pragmatic cluster randomized crossover trials investigating the use of different surgical skin preparation solutions, used to clean the skin prior to an operation. Once complete, these trials will provide data on over 3000 open fractures from sites around the world, including data on infection and unplanned reoperation rates. Secondary analysis of these trials will allow us to compare a cephalosporin plus aminoglycoside antibiotic regimen to piperacillin-tazobactam to determine if there are differences in the risk of surgical site infection or unplanned reoperation. This has the potential to change practice with regards to standard antibiotic prophylaxis for open fractures.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486306
Name
Gouveia Kyle J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cefazolin plus aminoglycoside compared to piperacillin-tazobactam for type 3 open fractures
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotics; Fracture; Infection; Orthopaedics; Trauma
Abstract
Open fractures represent a significant cause of morbidity worldwide, leading to disability and even the potential for limb loss. Moreover, the impact of these injuries disproportionately affects those in the developing world. While surgical treatment of these injuries is focused on thorough irrigation and debridement along with fracture stabilization, early antibiotic prophylaxis is consistently identified as one of the greatest contributors to decreasing the risk of surgical site infection (SSI). Guidelines currently recommend the use of a cephalosporin such as cefazolin for antibiotic prophylaxis, with the addition of an aminoglycoside for those more severe Type III open fractures in order to provide Gram-negative coverage. More recently, literature has demonstrated promise with regards to the use of piperacillin-tazobactam as an alternative to cefazolin plus an aminoglycoside, potentially avoiding the known complications of nephrotoxicity and ototoxicity associated with aminoglycosides.
The PREP-IT trials are a group of large, multicenter pragmatic cluster randomized crossover trials investigating the use of different surgical skin preparation solutions, used to clean the skin prior to an operation. Once complete, these trials will provide data on over 3000 open fractures from sites around the world, including data on infection and unplanned reoperation rates. Secondary analysis of these trials will allow us to compare a cephalosporin plus aminoglycoside antibiotic regimen to piperacillin-tazobactam to determine if there are differences in the risk of surgical site infection or unplanned reoperation. This has the potential to change practice with regards to standard antibiotic prophylaxis for open fractures.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gouveia, Kyle J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~